QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 accurays-president-and-chief-executive-officer-suzanne-winter-to-take-temporary-medical-leave-of-absence-sandeep-chalke-will-serve-as-interim-ceo-during-winters-absence

- SEC Filing

 accuray-secures-ce-mark-for-accuray-helix-a-ct-guided-helical-radiotherapy-system

The new system is intended for emerging markets where access to advanced cancer care, including radiotherapy treatments, is typ...

 russell-2000-set-for-strongest-session-in-a-month-as-us-economy-defies-recession-fears-small-cap-movers-on-thursday

Russell 2000 ETF (ARCA: IWM) up 2.7%, its strongest session in a month, driven by positive economic data & increased consum...

 accuray-q4-2024-gaap-eps-003-inline-sales-13430m-beat-12151m-estimate

Accuray (NASDAQ:ARAY) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. The company rep...

 accuray-announced-an-agreement-with-truenorth-medical-physics-to-provide-radiation-oncology-departments-with-third-party-support-designed-to-enhance-their-departments-capabilities

Under the terms of the agreement, TrueNorth Medical Physics will offer services that are complementary and supplementary to tho...

 accurays-precision-treatment-system-gains-approval-in-china-expanding-cancer-care-options

 Accuray Incorporated (NASDAQ:ARAY) announced today that the registration dossier for the Accuray Precision® Treatment Planning...

 accuray-q3-2024-gaap-eps-006-misses-001-estimate-sales-101132m-miss-113649m-estimate

Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by ...

 roth-mkm-initiates-coverage-on-accuray-with-buy-rating-announces-price-target-of-9

Roth MKM analyst Jason Wittes initiates coverage on Accuray (NASDAQ:ARAY) with a Buy rating and announces Price Target of $9.

 recap-accuray-q2-earnings
Recap: Accuray Q2 Earnings
01/31/2024 21:25:08

 accuray-q2-eps-010-misses-005-estimate-sales-10724m-beat-10667m-estimate

Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.05) by ...

 earnings-scheduled-for-january-31-2024

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION